Literature DB >> 30429347

Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.

Markus Hoffmann1, Inga Nehlmeier2, Constantin Brinkmann2,3, Verena Krähling4, Laura Behner4, Anna-Sophie Moldenhauer2, Nadine Krüger5,6, Julia Nehls7,8, Michael Schindler7,8, Thomas Hoenen9, Andrea Maisner4, Stephan Becker4, Stefan Pöhlmann1,3.   

Abstract

Ebola virus (EBOV) and Nipah virus (NiV) infection of humans can cause fatal disease and constitutes a public health threat. In contrast, EBOV and NiV infection of fruit bats, the putative (EBOV) or proven (NiV) natural reservoir, is not associated with disease, and it is currently unknown how these animals control the virus. The human interferon (IFN)-stimulated antiviral effector protein tetherin (CD317, BST-2) blocks release of EBOV- and NiV-like particles from cells and is counteracted by the EBOV glycoprotein (GP). In contrast, it is unknown whether fruit bat tetherin restricts virus infection and is susceptible to GP-driven antagonism. Here, we report the sequence of fruit bat tetherin and show that its expression is IFN stimulated and associated with strong antiviral activity. Moreover, we demonstrate that EBOV-GP antagonizes tetherin orthologues of diverse species but fails to efficiently counteract fruit bat tetherin in virus-like particle (VLP) release assays. However, unexpectedly, tetherin was dispensable for robust IFN-mediated inhibition of EBOV spread in fruit bat cells. Thus, the VLP-based model systems mimicking tetherin-mediated inhibition of EBOV release and its counteraction by GP seem not to adequately reflect all aspects of EBOV release from IFN-stimulated fruit bat cells, potentially due to differences in tetherin expression levels that could not be resolved by the present study. In contrast, tetherin expression was essential for IFN-dependent inhibition of NiV infection, demonstrating that IFN-induced fruit bat tetherin exerts antiviral activity and may critically contribute to control of NiV and potentially other highly virulent viruses in infected animals.IMPORTANCE Ebola virus and Nipah virus (EBOV and NiV) can cause fatal disease in humans. In contrast, infected fruit bats do not develop symptoms but can transmit the virus to humans. Why fruit bats but not humans control infection is largely unknown. Tetherin is an antiviral host cell protein and is counteracted by the EBOV glycoprotein in human cells. Here, employing model systems, we show that tetherin of fruit bats displays higher antiviral activity than human tetherin and is largely resistant against counteraction by the Ebola virus glycoprotein. Moreover, we demonstrate that induction of tetherin expression is critical for interferon-mediated inhibition of NiV but, for at present unknown reasons, not EBOV spread in fruit bat cells. Collectively, our findings identify tetherin as an antiviral effector of innate immune responses in fruit bats, which might allow these animals to control infection with NiV and potentially other viruses that cause severe disease in humans.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Ebola virus; Nipah virus; bat; tetherin

Mesh:

Substances:

Year:  2019        PMID: 30429347      PMCID: PMC6340021          DOI: 10.1128/JVI.01821-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

2.  Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.

Authors:  Andrea Hanika; Birthe Larisch; Eike Steinmann; Christel Schwegmann-Weßels; Georg Herrler; Gert Zimmer
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

3.  Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008.

Authors:  Muhammad Aziz Rahman; Mohammad Jahangir Hossain; Sharmin Sultana; Nusrat Homaira; Salah Uddin Khan; Mahmudur Rahman; Emily S Gurley; Pierre E Rollin; Michael K Lo; James A Comer; Luis Lowe; Paul A Rota; Thomas G Ksiazek; Eben Kenah; Yushuf Sharker; Stephen P Luby
Journal:  Vector Borne Zoonotic Dis       Date:  2011-09-16       Impact factor: 2.133

4.  Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.

Authors:  Jonas Fuchs; Martin Hölzer; Mirjam Schilling; Corinna Patzina; Andreas Schoen; Thomas Hoenen; Gert Zimmer; Manja Marz; Friedemann Weber; Marcel A Müller; Georg Kochs
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses.

Authors:  David T S Hayman; Petra Emmerich; Meng Yu; Lin-Fa Wang; Richard Suu-Ire; Anthony R Fooks; Andrew A Cunningham; James L N Wood
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

6.  Nipah virus entry and egress from polarized epithelial cells.

Authors:  Boris Lamp; Erik Dietzel; Larissa Kolesnikova; Lucie Sauerhering; Stephanie Erbar; Hana Weingartl; Andrea Maisner
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

7.  Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010.

Authors:  Michael K Lo; Luis Lowe; Kimberly B Hummel; Hossain M S Sazzad; Emily S Gurley; M Jahangir Hossain; Stephen P Luby; David M Miller; James A Comer; Pierre E Rollin; William J Bellini; Paul A Rota
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

8.  Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.

Authors:  Markus Hoffmann; Marcel Alexander Müller; Jan Felix Drexler; Jörg Glende; Meike Erdt; Tim Gützkow; Christoph Losemann; Tabea Binger; Hongkui Deng; Christel Schwegmann-Weßels; Karl-Heinz Esser; Christian Drosten; Georg Herrler
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 9.  The antiviral activities of tetherin.

Authors:  Stuart J D Neil
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Analysis of determinants in filovirus glycoproteins required for tetherin antagonism.

Authors:  Kerstin Gnirß; Marie Fiedler; Annika Krämer-Kühl; Sebastian Bolduan; Eva Mittler; Stephan Becker; Michael Schindler; Stefan Pöhlmann
Journal:  Viruses       Date:  2014-04-09       Impact factor: 5.048

View more
  7 in total

1.  Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.

Authors:  Teresa Plegge; Martin Spiegel; Nadine Krüger; Inga Nehlmeier; Michael Winkler; Mariana González Hernández; Stefan Pöhlmann
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

2.  Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.

Authors:  Mariana González-Hernández; Andreas Müller; Thomas Hoenen; Markus Hoffmann; Stefan Pöhlmann
Journal:  Virology       Date:  2019-04-03       Impact factor: 3.616

Review 3.  Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.

Authors:  Raj Kumar Singh; Kuldeep Dhama; Sandip Chakraborty; Ruchi Tiwari; Senthilkumar Natesan; Rekha Khandia; Ashok Munjal; Kranti Suresh Vora; Shyma K Latheef; Kumaragurubaran Karthik; Yashpal Singh Malik; Rajendra Singh; Wanpen Chaicumpa; Devendra T Mourya
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

4.  The N-glycosylation of Equine Tetherin Affects Antiviral Activity by Regulating Its Subcellular Localization.

Authors:  Bowen Bai; Xue-Feng Wang; Mengmeng Zhang; Lei Na; Xiangmin Zhang; Haili Zhang; Zhibiao Yang; Xiaojun Wang
Journal:  Viruses       Date:  2020-02-16       Impact factor: 5.048

Review 5.  Retroviral Restriction Factors and Their Viral Targets: Restriction Strategies and Evolutionary Adaptations.

Authors:  Guney Boso; Christine A Kozak
Journal:  Microorganisms       Date:  2020-12-11

Review 6.  Bat-borne virus diversity, spillover and emergence.

Authors:  Michael Letko; Stephanie N Seifert; Kevin J Olival; Raina K Plowright; Vincent J Munster
Journal:  Nat Rev Microbiol       Date:  2020-06-11       Impact factor: 78.297

Review 7.  Novel Insights Into Immune Systems of Bats.

Authors:  Arinjay Banerjee; Michelle L Baker; Kirsten Kulcsar; Vikram Misra; Raina Plowright; Karen Mossman
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.